case_images: PMC6055910_01
case_images: Psoriasiform skin lesions in the frontal scalp region (A), palms (B), soles (C), and fingernails (D).
case_images: btt-12-069Fig1.jpg
case_images: PMC6055910_01_btt-12-069Fig1.jpg
case_images: f1-btt-12-069
case_images: Two years after the start of treatment, he presented with palmoplantar pustulosis-like eruptions involving the palms of the hands and soles of the feet of both sides, followed by the appearance of scaly eruptions all over the body (Figure 1).
case_images: Swelling in the right knee joint (A) and complete healing of the lesion after therapy with ustekinumab (B).
case_images: btt-12-069Fig2.jpg
case_images: PMC6055910_01_btt-12-069Fig2.jpg
case_images: f2-btt-12-069
case_images: Eight months after the discontinuation of infliximab, the patient developed painful knee joint swelling (Figure 2A). Soon after the start of this treatment, the arthritis abated (Figure 2B), and within 2 months, the skin symptoms also resolved (PASI 0.8) (Figure 3).
case_images: Complete healing after one injection of ustekinumab in the frontal scalp region (A), palms (B), and fingernails (C).
case_images: btt-12-069Fig3.jpg
case_images: PMC6055910_01_btt-12-069Fig3.jpg
case_images: f3-btt-12-069
case_images: Soon after the start of this treatment, the arthritis abated (Figure 2B), and within 2 months, the skin symptoms also resolved (PASI 0.8) (Figure 3).